Abivax: Latest Obefazimod Data Eases Safety Fears, Brings M&A Back Into Play
AI Summary
Abivax reported new safety data on Obefazimod that alleviated previous concerns and rekindled interest in potential mergers and acquisitions involving the company. The development has implications for its valuation and strategic transactions.